blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2125747

EP2125747 - 1,5-DIARYL-PYRAZOLES AS CANNABINOID RECEPTOR NEUTRAL ANTAGONISTS USEFUL AS THERAPEUTIC AGENTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.04.2011
Database last updated on 31.05.2024
Most recent event   Tooltip15.04.2011Application deemed to be withdrawnpublished on 18.05.2011  [2011/20]
Applicant(s)For all designated states
The University Court of The University of Aberdeen
Regent Walk Aberdeen
Aberdeenshire AB24 3FX / GB
[2009/49]
Inventor(s)01 / GREIG, Iain, Robert
Institute of Medical Sciences University of Aberdeen Medical School
Foresterhill Aberdeenshire AB25 2ZD / GB
02 / ROSS, Ruth, Alexandra
Institute of Medical Sciences University of Aberdeen Medical School
Foresterhill Aberdeenshire AB25 2ZD / GB
03 / PERTWEE, Roger, Guy
Institute of Medical Sciences University of Aberdeen Medical School
Foresterhill Aberdeenshire AB25 2ZD / GB
 [2009/49]
Representative(s)Wytenburg, Wilhelmus Johannes
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2009/49]Wytenburg, Wilhelmus Johannes
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date08709342.307.02.2008
[2009/49]
WO2008GB00435
Priority number, dateGB2007000286214.02.2007         Original published format: GB 0702862
[2009/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008099139
Date:21.08.2008
Language:EN
[2008/34]
Type: A1 Application with search report 
No.:EP2125747
Date:02.12.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 21.08.2008 takes the place of the publication of the European patent application.
[2009/49]
Search report(s)International search report - published on:EP21.08.2008
ClassificationIPC:C07D231/12, A61K31/415, A61P29/00
[2009/49]
CPC:
C07D231/12 (EP,US); A61P19/00 (EP); A61P25/00 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P37/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/49]
TitleGerman:1,5-DIARYLPYRAZOLE ALS NEUTRALE CANNABINOIDREZEPTORANTAGONISTEN, DIE SICH ALS THERAPEUTISCHE MITTEL EIGNEN[2009/49]
English:1,5-DIARYL-PYRAZOLES AS CANNABINOID RECEPTOR NEUTRAL ANTAGONISTS USEFUL AS THERAPEUTIC AGENTS[2009/49]
French:1,5-DIARYL-PYRAZOLES COMME ANTAGONISTES NEUTRES DES RÉCEPTEURS CANNABINOÏDES, UTILES COMME AGENTS THÉRAPEUTIQUES[2009/49]
Entry into regional phase04.09.2009National basic fee paid 
04.09.2009Designation fee(s) paid 
04.09.2009Examination fee paid 
Examination procedure04.09.2009Examination requested  [2009/49]
09.10.2009Amendment by applicant (claims and/or description)
12.05.2010Despatch of a communication from the examining division (Time limit: M06)
23.11.2010Application deemed to be withdrawn, date of legal effect  [2011/20]
30.12.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/20]
Fees paidRenewal fee
23.02.2010Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
28.02.201104   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]US6509367  (MARTIN BILLY R [US], et al) [AD] 1-149 * table 2 *;
 [X]US2003199536  (THOMAS BRIAN F [US], et al) [X] 1-20,51-89,93-149 * Table 4, compound AM-50 *;
 [X]WO2004052864  (PFIZER PROD INC [US], et al) [X] 1-21,51-89,93-149 * Table I, examples 1A-16, 1A-25, 1A-28, 1A-58, 1A-60, 1A-99, 1A-127, 1A-132, 1A-137, 1A-150;;; claim 1 *;
 [A]US2006100208  (MAKRIYANNIS ALEXANDROS [US], et al) [A] 1-149* page 16, compound I-28 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.